NTLX Neurothera Labs Inc.

2.796USD4.000 CAD · TSXV0.00%Mkt Cap: 237.40M USDP/E: —

Neurothera Labs Inc. engages in the development of a portfolio of drugs based on cannabinoid molecules. The company develops programs based on tetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol for the treatm…